Locations:
Min Investment:
Max Investment:
Target Investment:
2019
2019
2021
2002
2022
2022
2022
Therapeutics company developing broad antiviral therapy for influenza, Coronavirus and other respiratory pathogens
2020
2020
Diagnostic company developing tests for MRD in lymphoma and solid tumors. Series A with Stanford founders.
2020
2020
2019
2019
2019
2019
2016
2016